The neffyinSchools program from ARS Pharma will provide eligible public and private K-12 schools in the United States with ...

Compared with placebo, zavegepant nasal spray yielded sustained relief of acute pain and function in migraine.

Ocean Spray is bringing the bright, refreshing flavors of the tropics nationwide with the launch of its new Ocean Spray Zero ...

Cognitive neuroscientist Eleanor Maguire, PhD, whose studies of London taxi drivers' brains helped transform memory research, ...

Ocean Spray is challenging Australians to rethink how they elevate their every day with the launch of its bold and interactive campaign, Is There Anything PURE Can’t Improve? Designed to spark ...

The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for bumetanide nasal spray (RSQ-777) for the treatment of edema associated with congestive heart failure, ...

A Prescription Drug User Fee Act target date of September 14, 2025 has been assigned to the application. The Food and Drug Administration (FDA) has accepted for review the New Drug Application ...

The Food and Drug Administration (FDA) has expanded its approval of a ketamine-derived nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment-resistant depression.

The FDA’s latest approval of the nasal spray Spravato (esketamine) CIII marks a major shift in how major depressive disorder is managed, allowing people who have tried at least two oral ...

Share on Pinterest The FDA has approved an esketamine nasal spray for the treatment of depression cases that do not respond to other therapeutic approaches. Image credit: Koldunov/Getty Images.

The global landscape of neurological health is undergoing a transformative moment with a pioneering nasal spray that could potentially revolutionize Alzheimer‘s disease management. As ...